| 注册
首页|期刊导航|药物分析学报(英文)|18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs

18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs

Qian Zhang Liwei Gu Jiahao Li Qiuyan Guo Chuanbin Yang Yin Kwan Wong Fei Xia Jigang Wang Piao Luo Liuhai Zheng Jiayun Chen Junzhe Zhang Huan Tang Dandan Liu Xueling He Qiaoli Shi

药物分析学报(英文)2022,Vol.12Issue(4):570-582,13.
药物分析学报(英文)2022,Vol.12Issue(4):570-582,13.

18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs

18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs

Qian Zhang 1Liwei Gu 2Jiahao Li 1Qiuyan Guo 1Chuanbin Yang 1Yin Kwan Wong 2Fei Xia 3Jigang Wang 1Piao Luo 1Liuhai Zheng 1Jiayun Chen 2Junzhe Zhang 2Huan Tang 1Dandan Liu 1Xueling He 1Qiaoli Shi1

作者信息

  • 1. Artemisinin Research Center and Institute of Chinese Materia Medica,Chinese Academy of Chinese Medical Sciences,Beijing,100700,China
  • 2. Department of Geriatrics,Shenzhen People's Hospital(The Second Clinical Medical College,Jinan University),Shenzhen,518020,China
  • 3. Department of Biological Sciences,National University of Singapore,Singapore,117543,Singapore
  • 折叠

摘要

关键词

Glycyrrhetinic acid/Hepatic fibrosis/Peroxiredoxin/Reactive oxygen species/Apoptosis

Key words

Glycyrrhetinic acid/Hepatic fibrosis/Peroxiredoxin/Reactive oxygen species/Apoptosis

引用本文复制引用

Qian Zhang,Liwei Gu,Jiahao Li,Qiuyan Guo,Chuanbin Yang,Yin Kwan Wong,Fei Xia,Jigang Wang,Piao Luo,Liuhai Zheng,Jiayun Chen,Junzhe Zhang,Huan Tang,Dandan Liu,Xueling He,Qiaoli Shi..18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs[J].药物分析学报(英文),2022,12(4):570-582,13.

基金项目

The authors gratefully acknowledge the financial support from the Innovation Team and Talents Cultivation Program of the Na-tional Administration of Traditional Chinese Medicine,China(Grant No.:ZYYCXTD-C-202002),the National Key Research and Devel-opment Program of China,China(Grant No.:2020YFA0908000),the National Natural Science Foundation of China,China(Grant Nos.:81803389,81903588,32101219,81702580,82074098,81903866,and 81803456),and the Fundamental Research Funds for the Central Public Welfare Research Institutes,China(Grant Nos.:ZZ14-YQ-050,ZZ14-YQ-059,ZZ15-ND-10,ZZ15-YQ-063,ZZ14-ND-010,and ZZ14-FL-002). (Grant No.:ZYYCXTD-C-202002)

药物分析学报(英文)

OACSCDSCI

2095-1779

访问量0
|
下载量0
段落导航相关论文